Sandbox lung cancer differential: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
!Immunohistochemistry
!Immunohistochemistry
!Imaging
!Imaging
!Mets
!Metastasis
|-
|-
| rowspan="2" |Papilloma<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| rowspan="2" |'''[[Papilloma]]'''<ref name="pmid3969658">{{cite journal |vauthors=Maxwell RJ, Gibbons JR, O'Hara MD |title=Solitary squamous papilloma of the bronchus |journal=Thorax |volume=40 |issue=1 |pages=68–71 |date=January 1985 |pmid=3969658 |pmc=459982 |doi= |url=}}</ref>
| colspan="2" |Squamous cell papilloma
| colspan="2" |'''[[Squamous cell papilloma]]'''
|
|
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* Men
* Men
* Median age of diagnosis is 54 years
* Median age of diagnosis is 54 years
|
|
* Epithelial cells
* [[Epithelial cells]]
|
|
* Endobronchial
* Endobronchial
Line 36: Line 36:
** Acanthosis
** Acanthosis
** Binucleate forms and perinuclear halos
** Binucleate forms and perinuclear halos
** Koilocytosis
** [[Koilocytosis]]
|
|
* N/A
* N/A
| rowspan="3" |
|
* Well circumscribed\
* Well circumscribed
* Homogenous
* Homogenous
* Non-calcified
* Non-calcified
Line 47: Line 47:
* N/A
* N/A
|-
|-
| colspan="2" |Glandular papilloma
| colspan="2" |'''Glandular papilloma'''
|
|
* Rare
* Rare
* Mean age of diagnosis is 68
* Mean age of diagnosis is 68 years
|
|
* Goblet cells of respiratory epithelium
* [[Goblet cells]] of [[respiratory epithelium]]
|
|
* Endobronchial
* Endobronchial
|
|
* White to tan endobronchial polyps that measure from 0.7-1.5 cm
* White to tan endobronchial [[Polyp|polyps]] that measure from 0.7-1.5 cm
|
|
* Thick arborizing stromal stalks
* Thick arborizing stromal stalks
* Thin-walled blood vessels
* Thin-walled [[blood vessels]]
* Nonciliated or ciliated epithelium
* Non-ciliated or ciliated [[epithelium]]
|
|
* N/A
* N/A
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
|
* N/A
* N/A
|-
|-
| rowspan="3" |Adenoma<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| rowspan="3" |'''Adenom'''a<ref name="pmid9817965">{{cite journal |vauthors=Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K |title=Solitary bronchioloalveolar adenoma of the lung |journal=Respiration |volume=65 |issue=6 |pages=483–5 |date=1998 |pmid=9817965 |doi=10.1159/000029319 |url=}}</ref>
| colspan="2" |Alveolar adenoma
| colspan="2" |'''Alveolar adenoma'''
|
|
* Mean age of diagnosis is 53 years
* Mean age of diagnosis is 53 years
* Female predominance
* Female predominance
|
|
* Alveolar pneumocytes
* Alveolar [[pneumocytes]]
* Septal mesenchyme
* Septal [[mesenchyme]]
|
|
* All lung lobes
* All lung lobes
Line 80: Line 85:
|
|
* 0.7-6.0 cm  
* 0.7-6.0 cm  
* well demarcated smooth
* Well demarcated smooth
* Lobulated, multicystic
* Lobulated, multicystic
* Soft to firm
* Soft to firm
* Pale yellow to tan cut surfaces
* Pale yellow to tan cut surfaces
|
|
* Unencapsulated
* Uncapsulated
* Multicystic masses
* Multicystic masses
* Cuboidal cell linning
* [[Cuboidal cells|Cuboidal cell]] linning
* Squamous metaplasia  
* Squamous metaplasia  
* Myxoid and collagenous interstitium  
* Myxoid and [[Collagen|collagenous]] interstitium  
|
|
* Keratin
* [[Keratin]]
* CEA
* [[CEA]]
* Surfactant protein  
* Surfactant protein  
* TTF-1  
* [[TTF-1]]
* Actin
* [[Actin]]
|
* Well circumscribed
* Homogenous
* Non-calcified
* Solitary mass
|
|
* N/A
* N/A
|-
|-
| colspan="2" |Papillary adenoma<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
| colspan="2" |'''Papillary adenoma'''<ref name="pmid28409070">{{cite journal |vauthors=Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D |title=A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung |journal=Cureus |volume=9 |issue=3 |pages=e1069 |date=March 2017 |pmid=28409070 |pmc=5375953 |doi=10.7759/cureus.1069 |url=}}</ref>
|
|
* Mean age of diagnosis is 32 years
* Mean age of diagnosis is 32 years
* Male predominance
* Male predominance
|
|
Line 115: Line 125:
* 1.0- 4.0 cm  
* 1.0- 4.0 cm  
|
|
* Infiltration.
* [[Infiltration (medical)|Infiltration]]
* Papillary growth pattern  
* [[Papillary]] growth pattern  
* Fibrovascular cores  
* Fibrovascular cores  
* Cuboidal to columnar epithelial linning
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* Cilitated and oxyphilic cells  
* Cilitated and oxyphilic cells  
* Occasional eosinophilic intranuclear inclusions
* Occasional [[eosinophilic]] intranuclear inclusions
|
|
* Cytokeratin
* [[Cytokeratin]]
* Clara cell protein
* [[Clara cell secretory protein|Clara cell protein]]
* TTF-1
* [[TTF-1]]
* Surfactant apoprotein
* Surfactant apoprotein
* CEA.
* [[CEA]]
|
|
* Incidental finding
* Incidental finding
Line 132: Line 142:
* N/A
* N/A
|-
|-
| colspan="2" |Mucinous cystadenoma
| colspan="2" |'''Mucinous cystadenoma'''
|
|
* No sex predilection  
* No sex predilection  
* Mean age of diagnosis is 52 years
* Mean age of diagnosis is 52 years
|
|
* Mucus glands of the bronchus
* Mucus glands of the [[bronchus]]
|
|
* Central
* Central
Line 146: Line 156:
* 0.7-7.5 cm
* 0.7-7.5 cm
|
|
* Numerous mucin-filled cystic spaces  
* Numerous [[mucin]]-filled cystic spaces  
* Non-dilated microacini, glands, tubules and papillae
* Non-dilated microacini, glands, tubules and papillae
|
|
* EMA
* EMA
* Cytokeratins  
* [[Cytokeratin|Cytokeratins]]
* CEA
* [[CEA]]
|
|
* Coin lesion.
* Coin lesion  
* Air-meniscus sign
* Air-meniscus sign
|
|
Line 160: Line 170:
! colspan="11" |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
! colspan="11" |Malignant Lung Tumors<ref name="pmid7863581">{{cite journal |vauthors=Kelley LC, Puette M, Langheinrich KA, King B |title=Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry |journal=Vet. Pathol. |volume=31 |issue=6 |pages=658–62 |date=November 1994 |pmid=7863581 |doi=10.1177/030098589403100605 |url=}}</ref>
|-
|-
! colspan="3" |Variant of lung carci
! colspan="3" |Variants of lung carcinoma
 
mao
!Risk Factors/Epidemiology
!Risk Factors/Epidemiology
!Pleuripotent cell
!Pleuripotent cell
Line 170: Line 178:
!Immunohistochemistry
!Immunohistochemistry
!Imaging
!Imaging
!Mets
!Metastasis
|-
|-
| rowspan="4" |'''Squamous cell carcinoma'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| rowspan="4" |'''Squamous cell carcinoma'''<ref name="pmid5528918">{{cite journal |vauthors=Roth E, Smidt D |title=[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs] |language=German |journal=Berl. Munch. Tierarztl. Wochenschr. |volume=83 |issue=1 |pages=7–11 |date=January 1970 |pmid=5528918 |doi= |url=}}</ref>
| colspan="2" |Papillary
| colspan="2" |'''Papillary'''
| rowspan="4" |
| rowspan="4" |
* Cigarette smokers  
* Cigarette smokers  
Line 201: Line 209:
| rowspan="4" |
| rowspan="4" |
|-
|-
| colspan="2" |Clear cell
| colspan="2" |'''Clear cell'''
|
|
* Cells with clear cytoplasm
* Cells with clear cytoplasm
|-
|-
| colspan="2" |Small cell
| colspan="2" |'''Small cell'''
|
|
* Poorly differentiated cells
* Poorly differentiated cells
Line 212: Line 220:
* Intercellular bridges or keratinization.
* Intercellular bridges or keratinization.
|-
|-
| colspan="2" |Basaloid
| colspan="2" |'''Basaloid'''
|
|
* Peripheral palisading of nuclei.
* Peripheral palisading of nuclei.
Line 248: Line 256:
* Liver metastases
* Liver metastases
|-
|-
| rowspan="10" |'''Adeno carcinoma<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>'''
| rowspan="10" |'''Adeno carcinoma'''<ref name="Kumar-adenocarcinoma">{{cite book |chapter=Chapter 13, box on morphology of adenocarcinoma |author=Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson |title=Robbins Basic Pathology|publisher=Saunders |location=Philadelphia |isbn=1-4160-2973-7 |edition=8th}}</ref><ref name="pmid17625570">{{cite journal| author=Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al.| title=Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. | journal=Nature | year= 2007 | volume= 448 | issue= 7153 | pages= 561-6 | pmid=17625570 | doi=10.1038/nature05945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17625570  }}</ref><ref>Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg</ref>
| colspan="2" |Acinar adenocarcinoma
| colspan="2" |'''Acinar adenocarcinoma'''
| rowspan="10" |
| rowspan="10" |
* Smokers
* Smokers
Line 288: Line 296:
* Liver
* Liver
|-
|-
| colspan="2" |Papillary adenocarcinoma
| colspan="2" |'''Papillary adenocarcinoma'''
|
|
* Papillae  
* Papillae  
Line 296: Line 304:
* Mucinous or non-mucinous
* Mucinous or non-mucinous
|-
|-
| rowspan="3" |Bronchio-alveolar carcinoma
| rowspan="3" |'''Bronchio-alveolar carcinoma'''
|Non-mucinous
|'''Non-mucinous'''
|
|
* Clara cells
* Clara cells
* Type II cells
* Type II cells
|-
|-
|Mucinous
|'''Mucinous'''
|
|
* Low grade differentiation
* Low grade differentiation
Line 312: Line 320:
* Cytologic atypia  
* Cytologic atypia  
|-
|-
|Mixed non-mucinous and mucinous or indeterminate
|'''Mixed non-mucinous and mucinous or indeterminate'''
|
|
|-
|-
| rowspan="5" |Solid adenocarcinoma with mucin production
| rowspan="5" |'''Solid adenocarcinoma with mucin production'''
|Fetal adenocarcinoma
|'''Fetal adenocarcinoma'''
|
|
* Consists glandular elements
* Consists glandular elements
Line 324: Line 332:
** Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
** Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
|-
|-
|Mucinous (“colloid”) carcinoma
|'''Mucinous (“colloid”) carcinoma'''
|
|
* Dissecting pools of mucin containing neoplastic cells.
* Dissecting pools of mucin containing neoplastic cells.
|-
|-
|Mucinous cystadenocarcinoma
|'''Mucinous cystadenocarcinoma'''
|
|
* Partial fibrous tissue capsule.  
* Partial fibrous tissue capsule.  
Line 334: Line 342:
* Neoplastic mucinous epithelium grows along alveolar walls.
* Neoplastic mucinous epithelium grows along alveolar walls.
|-
|-
|Signet ring adenocarcinoma
|'''Signet ring adenocarcinoma'''
|
|
|-
|-
|Clear cell adenocarcinoma
|'''Clear cell adenocarcinoma'''
|
|
|-
|-
| rowspan="5" |'''Large cell carcinoma'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| rowspan="5" |'''Large cell carcinoma'''<ref name="pmid24221342">{{cite journal |vauthors=Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G |title=Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology |journal=Virchows Arch. |volume=464 |issue=1 |pages=61–8 |date=January 2014 |pmid=24221342 |doi=10.1007/s00428-013-1501-6 |url=}}</ref>
| colspan="2" |Basaloid large cell carcinoma of the lung
| colspan="2" |'''Basaloid large cell carcinoma of the lung'''
| rowspan="5" |
| rowspan="5" |
* Approximately 10% of lung cancers.
* Approximately 10% of lung cancers.
Line 378: Line 386:
* Pericardium
* Pericardium
|-
|-
| colspan="2" |Clear cell carcinoma of the lung
| colspan="2" |'''Clear cell carcinoma of the lung'''
|
|
* Clear cells
* Clear cells
|-
|-
| colspan="2" |Lymphoepithelioma-like carcinoma of the lung
| colspan="2" |'''Lymphoepithelioma-like carcinoma of the lung'''
|
|
* Syncytial growth pattern
* Syncytial growth pattern
Line 390: Line 398:
* [[amyloid]] deposition
* [[amyloid]] deposition
|-
|-
| colspan="2" |Large-cell lung carcinoma with rhabdoid phenotype
| colspan="2" |'''Large-cell lung carcinoma with rhabdoid phenotype'''
|
|
* Eosinophilic cytoplasmic globules
* Eosinophilic cytoplasmic globules
Line 396: Line 404:
* Eosinophilic inclusions
* Eosinophilic inclusions
|-
|-
| colspan="2" |Mixed type
| colspan="2" |'''Mixed type'''
|
|
* Mixture of  
* Mixture of  
Line 405: Line 413:
|-
|-
| rowspan="5" |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| rowspan="5" |'''Sarcomatoid carcinoma'''<ref name="pmid24088577">{{cite journal |vauthors=Huang SY, Shen SJ, Li XY |title=Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases |journal=World J Surg Oncol |volume=11 |issue= |pages=252 |date=October 2013 |pmid=24088577 |pmc=3850921 |doi=10.1186/1477-7819-11-252 |url=}}</ref>
| colspan="2" |Carcinosarcoma
| colspan="2" |'''Carcinosarcoma'''
| rowspan="5" |
| rowspan="5" |
* Accounts for only 0.3-1.3% of all lung malignancies
* Accounts for only 0.3-1.3% of all lung malignancies
Line 436: Line 444:
* Kidney
* Kidney
|-
|-
| colspan="2" |Spindle cell carcinoma
| colspan="2" |'''Spindle cell carcinoma'''
|
|
* Only spindle shaped tumor cells
* Only spindle shaped tumor cells
Line 448: Line 456:
* TTF-1  
* TTF-1  
|-
|-
| colspan="2" |Giant cell carcinoma
| colspan="2" |'''Giant cell carcinoma'''
|
|
* Multi- and/or mononucleated tumor giant cells
* Multi- and/or mononucleated tumor giant cells
|-
|-
| colspan="2" |Pleomorphic carcinoma
| colspan="2" |'''Pleomorphic carcinoma'''
|
|
* Poorly differentiated
* Poorly differentiated
Line 458: Line 466:
* Fibrous or myxoid stroma
* Fibrous or myxoid stroma
|-
|-
| colspan="2" |Pulmonary blastoma
| colspan="2" |'''Pulmonary blastoma'''
|
|
* Biphasic  
* Biphasic  
Line 469: Line 477:
|-
|-
|'''Carcinoid tumor'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
|'''Carcinoid tumor'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| colspan="2" |Typical carcinoid
| colspan="2" |'''Typical carcinoid'''
Atypical carcinoid  
'''Atypical carcinoid'''
|
|
|
|
Line 503: Line 511:
|-
|-
| rowspan="3" |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>  
| rowspan="3" |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>  
| colspan="2" |Mucoepidermoid carcinoma
| colspan="2" |'''Mucoepidermoid carcinoma'''
|
|
* Most patients presents in the third and fourth decade
* Most patients presents in the third and fourth decade
Line 534: Line 542:
* Brain
* Brain
|-
|-
| colspan="2" |Adenoid cystic carcinoma
| colspan="2" |'''Adenoid cystic carcinoma'''
|
|
* Constitutes less than 1% of all lung tumors.
* Constitutes less than 1% of all lung tumors.
Line 571: Line 579:
* Adrenal glands
* Adrenal glands
|-
|-
| colspan="2" |Epithelial-myoepithelial carcinoma
| colspan="2" |'''Epithelial-myoepithelial carcinoma'''
|
|
* Age ranges from 33 to 71 years  
* Age ranges from 33 to 71 years  
Line 596: Line 604:
|-
|-
| rowspan="3" |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>  
| rowspan="3" |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>  
| colspan="2" |Squamous carcinoma in situ  
| colspan="2" |'''Squamous carcinoma in situ'''
| rowspan="3" |
| rowspan="3" |
* Most commonly seen in fifth or sixth decades
* Most commonly seen in fifth or sixth decades
Line 636: Line 644:
* Spleen
* Spleen
|-
|-
| colspan="2" |Atypical adenomatous hyperplasia  
| colspan="2" |'''Atypical adenomatous hyperplasia'''
|
|
* Surfactant apoprotein  
* Surfactant apoprotein  
Line 667: Line 675:
* Ground glass opacity  
* Ground glass opacity  
|-
|-
| colspan="2" |Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
| colspan="2" |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
|
|
* Pulmonary neuroendocrine cells
* Pulmonary neuroendocrine cells
Line 694: Line 702:
|-
|-
| rowspan="8" |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>  
| rowspan="8" |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>  
| colspan="2" |Epithelioid haemangioendothelioma / Angiosarcoma
| colspan="2" |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
|
|
* Caucasian
* Caucasian
Line 734: Line 742:
* Soft tissue
* Soft tissue
|-
|-
| colspan="2" |Pleuropulmonary blastoma
| colspan="2" |'''Pleuropulmonary blastoma'''
|
|
* Most common in children
* Most common in children
Line 772: Line 780:
* Pancreas
* Pancreas
|-
|-
| colspan="2" |Chondroma
| colspan="2" |'''Chondroma'''
|
|
* Young women
* Young women
Line 801: Line 809:
* Benign tumor
* Benign tumor
|-
|-
| colspan="2" |Congenital peribronchial myofibroblastic tumor
| colspan="2" |'''Congenital peribronchial myofibroblastic tumor'''
|
|
* Rare
* Rare
Line 832: Line 840:
|
|
|-
|-
| colspan="2" |Diffuse pulmonary lymphangiomatosis
| colspan="2" |'''Diffuse pulmonary lymphangiomatosis'''
|
|
* Children
* Children
Line 864: Line 872:
|
|
|-
|-
| colspan="2" |Inflammatory myofibroblastic tumor
| colspan="2" |'''Inflammatory myofibroblastic tumor'''
|
|
* Previous viral infections
* Previous viral infections
Line 907: Line 915:
* Rare
* Rare
|-
|-
| colspan="2" |Pulmonary artery sarcoma
| colspan="2" |'''Pulmonary artery sarcoma'''
|
|
* Mean age of diagnosis is 49.3 years
* Mean age of diagnosis is 49.3 years
Line 946: Line 954:
* Mediastinum
* Mediastinum
|-
|-
| colspan="2" |Pulmonary vein sarcoma
| colspan="2" |'''Pulmonary vein sarcoma'''
|
|
* Most common in women.
* Most common in women.

Revision as of 14:32, 21 March 2018

  • Differentiation of primary and secondary lung tumors is difficult due to overlapping histologic features.
  • Topography, size and form of pulmonary growth pattern are important aspects for the differential diagnosis.
  • The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]
Benign Lung Tumors[2]
Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[3] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
    • Loose fibrovascular core
    • Stratified squamous epithelium
    • Acanthosis
    • Binucleate forms and perinuclear halos
    • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[4] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[5]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[6]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma[7] Papillary
  • Cigarette smokers
  • Arsenic
  • Central
  • White or grey lesions
  • Focal carbon pigment deposits
  • Cavitations.
  • Intraluminal polypoid masses
  • Infiltration
  • Exophytic
  • Intra-epithelial
  • Without invasion
  • Keratin
  • Cytokeratins
  • CEA
  • Thyroid transcription factor-1 (TTF-1)
  • Lobar or entire lung collapse
  • Shift of the mediastinum to the ipsilateral side.
  • Hilar, perihilar or mediastinal masses
Clear cell
  • Cells with clear cytoplasm
Small cell
  • Poorly differentiated cells
  • Focal squamous
  • No characteristic nuclear features of SCC.
  • Intercellular bridges or keratinization.
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[8]
  • Smoking
  • Radon exposure
  • Bronchial precursor cell
  • White-tan, soft, friable perihilar masses.
  • Extensive necrosis.
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting,
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • CD56
  • Chromogranin
  • Synaptophysin
  • TTF-1
  • Hilar or perihilar masses
  • Mediastinal lymphadenopathy
  • Lobar collapse
  • Bone marrow
  • Liver metastases
Adeno carcinoma[9][10][11] Acinar adenocarcinoma
  • Smokers
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution.
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation.
    • Necrosis,
    • Cavitation
    • Hemorrhage.
  • Lobulated or ill defined edges.
  • Irregular-shaped glands
  • Malignant cells
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Epithelial markers (AE1/AE3, CAM 5.2)
  • Carcinoembryonic antigen
  • CK7
  • TTF-1
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
Papillary adenocarcinoma
  • Papillae
  • Necrosis
  • Surrounding invasion
  • Cuboidal to columnar epithemlial linning
  • Mucinous or non-mucinous
Bronchio-alveolar carcinoma Non-mucinous
  • Clara cells
  • Type II cells
Mucinous
  • Low grade differentiation
  • Composed of
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
  • Consists glandular elements
    • Tubules of glycogen-rich
    • Non-ciliated cells
    • Subnuclear and supranuclear glycogen vacuoles
    • Rounded morules of polygonal cells with abundant eosinophilic and finely granular cytoplasm.
Mucinous (“colloid”) carcinoma
  • Dissecting pools of mucin containing neoplastic cells.
Mucinous cystadenocarcinoma
  • Partial fibrous tissue capsule.
  • Central cystic change with mucin pooling
  • Neoplastic mucinous epithelium grows along alveolar walls.
Signet ring adenocarcinoma
Clear cell adenocarcinoma
Large cell carcinoma[12] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers.
  • Smoking
  • Neuro endocrine cells
  • Suprabasal bronchial cells.
  • Peripheral masses
  • Bronchi
  • Soft, pink-tan tumor
  • Necrosis and occasional hemorrhage
  • Cavitations.
  • Exophytic bronchial growth
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
  • Pleura
  • Liver
  • Bone
  • Brain
  • Abdominal lymph nodes
  • Pericardium
Clear cell carcinoma of the lung
  • Clear cells
Lymphoepithelioma-like carcinoma of the lung
  • Syncytial growth pattern
  • Eosinophilic nucleoli
  • Lymphocytic infiltration
  • Invasive
  • amyloid deposition
Large-cell lung carcinoma with rhabdoid phenotype
  • Eosinophilic cytoplasmic globules
  • Small foci of adenocarcinoma
  • Eosinophilic inclusions
Mixed type
Sarcomatoid carcinoma[13] Carcinosarcoma
  • Accounts for only 0.3-1.3% of all lung malignancies
  • Mean age at diagnosis is 60 years
  • Tobacco smoking
  • Asbestos exposure
  • Undifferentiated epithelial cells
  • Central or peripheral
  • Upper lobes
  • > 5 cm
  • Well circumscribed
  • Grey, yellow or tan creamy, gritty,
  • Mucoid and/or hemorrhagic with significant necrosis.
  • Sessile or pedunculated
  • Infiltrative
  • Biphasic
  • Mixture of carcinomatous and sarcomatous cells
  • Keratin
  • S-100
  • No specific imaging features 
  • Aggressive tumor
  • Esophagus, jejunum, rectum
  • Kidney
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
  • Keratin
  • EMA
  • Cytokeratin
  • Vimentin,
  • CEA
  • TTF-1
Giant cell carcinoma
  • Multi- and/or mononucleated tumor giant cells
Pleomorphic carcinoma
  • Poorly differentiated
  • Mixture of spindle cells and/or giant cells
  • Fibrous or myxoid stroma
Pulmonary blastoma
  • Biphasic
  • Mixture of epithelial and mesenchymal stroma
  • Keratin
  • EMA
  • CEA
  • Chromogranin A
Carcinoid tumor[14] Typical carcinoid

Atypical carcinoid

  • Neuroendocrine cells of lung
  • Typical carcinoids are throughout the lungs
  • AC is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors.
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
  • Cytokeratin
  • Chromogranin
  • Synaptophysin
  • Leu-7 (CD57)
  • N-CAM (CD56)
  • S-100 protein
  • Well defined pulmonary nodules
  • Calcifications is often seen.
  • Intense contrast enhancement.
  • Liver
  • Bone
Salivary gland tumors[15] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors.
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Exophytic endobronchial growth
  • Surface epithelium lacking changes of insitu carcinoma
  • Absence of individual cell keratinization
  • Transitional areas to low grade mucoepidermoid carcinoma.
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
  • Rare
  • Liver
  • Bones
  • Adrenal gland
  • Brain
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors.
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Trachea
  • Gray-white or tan polypoid lesions.
  • Size ranges from 1–4 cm
  • Infiltrative margins.
  • Invades other cell layers.
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Immunoperoxidase
  • Cytokeratin
  • Vimentin
  • Actin
  • Calponin
  • S-100 protein
  • p63
  • GFAP
  • Liver
  • Brain
  • Bone
  • Spleen
  • Kidney
  • Adrenal glands
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association between smoking
  • Myoepithelial cells
  • Endobronchia
  • Solid to gelatinous in texture
  • White to gray in colour
  • Myoepithelial cells
  • Dual layer of cells lining ducts.
  • Low mitotic activity.
  • MNF116
  • EMA
  • SMA and S-100
  • Reflects airway obstruction
  • Breast
Preinvasive lesions[16] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Bronchi
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Goblet cell hyperplasia
  • Basal cell hyperplasia
  • Squamous dysplasia
  • Angiogenic squamous dysplasia
  • Micropapillomatosis
  • EGFR
  • HER2/neu
  • p53
  • MCM2
  • Ki-67
  • Cytokeratin 5/6
  • bcl-2
  • VEGF
  • Folate binding protein
  • p16
  • Liver
  • Brain
  • Bone
  • Spleen
Atypical adenomatous hyperplasia
  • Surfactant apoprotein
  • Clara cell specific 10kDd protein
  • Pleura
  • Upper lobes
  • Multiple grey to yellow foci
  • 1mm to 10mm in size.
  • Intranuclear inclusions
  • Clara cells and type II pneumocytes.
  • Thickened alveolar walls
  • Discontinuous lining of cells
  • Moderate atypia.
  • Pseudopapillae
  • CEA
  • MMPs
  • E-cadherin,
  • ß-catenin,
  • CD44v6
  • TTF-1
  • TP53
  • Typically not visualized on radiographs.
  • Small non-solid nodules
  • Ground glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Pulmonary neuroendocrine cells
  • Endobronchial
  • Early lesions
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses.
  • Nodular aggregates
  • Fibrosis due to proliferation
  • Invade locally
  • Fibrous stroma aggregates to form ‘tumorlets’.
  • Carcinoids are tumorlets >5cm.
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Mesenchymal tumors[17] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women.
  • Endothelial cells
  • Intravascular
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency.
  • Round to oval-shaped nodules
    • Central sclerosis
    • Hypocellular zone
    • Peripheral cellular zone
    • Calcifications
    • Intranuclear cytoplasmic inclusions
  • CD31
  • CD34
  • factor VIII (von Willebrand factor)
  • Fli1
  • FKBP12
  • Cytokeratin
  • Multiple
  • Bilateral
  • Small nodules
  • 1-2 cm in size.
  • Can mimic pulmonary Langerhans’ cell histiocytosis.
  • Calcifications
  • Liver
  • Bone
  • Soft tissue
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years.
  • Thoracic splanchnopleural mesenchyme.
  • Pleura
  • Lung
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Type I
    • Purely cystic
    • Lined by respiratory type epithelium
    • Underneath malignant cells
  • Type II
    • Partial or complete overgrowth of the septal stroma
  • Type III
    • Mixed cells
  • Vimentin
  • S-100 protein
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
  • Brain
  • Spinal cord
  • Skeletal system
  • Eyes
  • Pancreas
Chondroma
  • Young women
  • Chondrocytes,
  • Cartilaginous cells
  • Peripheral lesions in lung
  • 1o seen in
    • Stomach
    • Bone
    • Paraganglia
  • Peripheral
  • Solid lesions
  • Calcified
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
  • Benign tumor
Congenital peribronchial myofibroblastic tumor
  • Rare
  • Sporadic
  • Complicated by
    • Polydramnios
    • Non-immune hydrops fetalis
  • Spindle cells
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance.
    • Haemorrhage
    • Necrosis
  • Fascicles of spindle cells.
  • Bronchial invasion
  • Peribronchial distribution
  • Cystic foci of haemorrhage
  • Vimentin
  • Well circumscribed
  • Opacifying the hemithorax
  • Heterogeneous mass
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Smooth muscles cells of lymphatic vessels.
  • Along the lymphatic distribution.
  • Prominence of the bronchovascular bundles along
    • Pleura
    • Interlobular pulmonary septa
    • Mediastinum
  • Anastomosing endothelial-lined cells along lymphatic routes.
  • Spindle cells
  • Intra alveolar siderophages
  • FVIIIrAg
  • Vimentin
  • UEA
  • Increased interstitial markings
  • Thickening of the
    • Interlobular septa
    • Fissures
    • Central airways
    • Pleura
Inflammatory myofibroblastic tumor
  • Previous viral infections
  • HHV8
  • Children
  • Myofibroblastic cells
  • Localized to bronchia
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non encapculated
  • Calcifications
  • No local invasion
  • Mixture of spindle cells
    • Fibroblastic
    • Myofibroblastic
  • Arranged in fascicles
  • Cytologic atypia
  • Touton type giant cells.
  • Plasma cells
  • Lymphoid follicles
  • Vimentin
  • Actin
  • ALK1
  • p80
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
    • Post-obstructive pneumonia
    • Atelectasis
  • Rare
Pulmonary artery sarcoma
  • Mean age of diagnosis is 49.3 years
  • Commonly misdiagnosed as PE
  • Mesenchymal cells of the intima
  • Primitive cells of the bulbus cordi in the trunk of pulmonary artery.
  • Pulmonary trunk most commonly
    • Right pulmonary artery
    • Left pulmonary artery
    • Pulmonary valve,
    • Right ventricular outflow tract
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Haemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
  • Vimentin
  • Osteopontin
  • Factor VIII
  • CD31
  • CD34
  • Findings overlap with those of chronic thromboembolic disease
  • Decreased vascularity
  • Heterogeneous soft tissue density
  • Smooth vascular tapering
  • Lung
  • Mediastinum
Pulmonary vein sarcoma
  • Most common in women.
  • Mean age of diagnosis is 49.
  • Smooth muscle
  • Pulmonary vein
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel.
  • 3.0- 20.0 cm
  • Invasion of wall of the vein.
  • Smooth muscle differentiation
  • Moderate to highly cellular spindle cell neoplasms
  • Epithelioid morphology
  • Vimentin
  • Desmin and actin
  • Keratin
  • N/A

Differentiation of lung cancer from other diseases with similar presentation

The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[18][19][20][21][22]

Disease Clinical features

Signs & symptoms

Radiological Findings Characterstic feature
Fever Cough Hemoptysis Dyspnea Chest pain Weight loss Night sweats
High-grade Low grade Productive Dry
Acute Lung abscess + - + - - - + - -
  • Air fluid level
Malignancy

(primary lung cancer)

- + - + + - - + +
  • Coin-shaped lesion
  • Thick wall(>15mm)
  • Ground glass opacities 
  • Long H/o smoking
  • Elderly male or female
  • BAL positive for malignant cells
  • CT guided biopsy is required for confirmation and differnatiation
Pulmonary Tuberculosis + - + - + - - - +
  • Cavitations in the upper lobe of the lung
Necrotizing Pneumonia + - + + - + - -
  • Multiple cavitary lesions
  • Acute life threatening condition
  • Complication of pneumonia or lung abscess
  • Multiple organisms responsible
  • prompt treatment with antibiotics is required
  • CBC positive for causative organism
Empyema + - + - + + + - -
  • Blood culture positive for causative agent.
Bronchiectasis - - + - + - - - -
  • Linear lucencies
  • Tram tracking appearance
  • Clustered cysts
  • CT confirms the diagnosis .
Wegners granulomatosis - - + + + - - -
  • Seen mostly in female age group of 40-55 years
  • Traid of Upper , lower respiratory tract and kidney disease
  • Biopsy of involved organ confirms granulomas
Sarcoidosis + - + - + - - + +
Rheumatoid nodule - - - - - + - + -
Langerhans cell Histiocytosis - - - - - + + + -
  • Thin-walled cystic cavities
  • Exclusively afflicts smokers.
  • Musculoskeletal and skin is involved
  • Biopsy of the involved organ
Bronchiolitis obliterans - - + - + + + - -
  • Ground-glass opacities
  • Nodules.
  • Biopsy

References

  1. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  2. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  3. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  4. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  5. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  6. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  7. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  8. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  9. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  10. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  11. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  12. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  13. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  14. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  15. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  16. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  17. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  18. Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  19. Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  20. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  21. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  22. Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.